Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
| Revenue (TTM) | $12.18B |
| Gross Profit (TTM) | $3.06B |
| EBITDA | $2.88B |
| Operating Margin | 20.50% |
| Return on Equity | 9.72% |
| Return on Assets | 4.96% |
| Revenue/Share (TTM) | $22.03 |
| Book Value | $23.40 |
| Price-to-Book | 1.61 |
| Price-to-Sales (TTM) | 1.72 |
| EV/Revenue | 2.247 |
| EV/EBITDA | 9.62 |
| Quarterly Earnings Growth (YoY) | 14.70% |
| Quarterly Revenue Growth (YoY) | 8.60% |
| Shares Outstanding | $546.93M |
| Float | $486.56M |
| % Insiders | 7.38% |
| % Institutions | 51.46% |
Volatility is currently expanding
Jan Philipp Jenisch purchased 30,000 shares for a total consideration of ~$1.3 million on September 2, 2026. The transaction involved shares equal to 1% of the total equity stake held before the filing.
Investors need to pay close attention to AMRZ stock based on the movements in the options market lately.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa, who is stepping down from the role and is committed to a smooth transition. Gross has been a member of Amrize's Executive Committee as its Chief Supply Chain Officer since the company's listing on the NYSE in June 2025. He previously served as Chief Operating Officer of the Building Envelope bus.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, who is stepping down for personal reasons. The company has also named Dillon Cumming as vice president of Investor Relations. Poletti has been a member of Amrize's Executive Committee as its Chief Strategy and M&A Officer since the company's listing on the NYSE in June 2025. Poletti led the succe.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) has filed its Form 10-Q for the Second Quarter and First Half Year 2026 with the U.S. Securities and Exchange Commission. The report is also available on Amrize's website at https://investors.amrize.com/ About Amrize Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) announced today its second quarter 2026 financial results1. Jan Jenisch, Chairman and CEO: "We delivered strong revenue growth of 8.6% in the second quarter driven by increased mega-project demand from data centers and energy to advanced manufacturing plants and infrastructure modernization. With the strength of our network and strategic footprint in the most attractive markets, we were able to achieve industry-leading organic growth of.
Amrize Ltd (AMRZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will release its second quarter 2026 financial results after the U.S. market closes on Thursday, August 6, 2026, followed by a live webcast to discuss the company's financial results at 7:30 am Central Time on Friday, August 7, 2026. Registration for the live webcast can be completed at https://amrize-quarterly-results-q2-2026.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in the eve.
Amrize is rated a cautious Buy, supported by strong Building Materials performance and a $1B buyback program. Building Materials delivered double-digit volume growth and margin expansion, driving operating leverage and supporting 8–11% adjusted EBITDA growth guidance. Building Envelope remains a weakness due to roofing headwinds, but resolved plant disruptions and price increases could enable a second-half recovery.
SAINT-CONSTANT, Quebec--(BUSINESS WIRE)--Amrize (NYSE: AMRZ) today broke ground on the modernization of its cement plant outside Montreal to be the most advanced and sustainable in Eastern Canada. As the largest investment in the Canadian cement industry over the last decade, the project will introduce state-of-the-art operational efficiency and enhanced sustainability, while expanding local manufacturing and production capacity. The investment reflects Amrize's commitment to strengthen supply.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMRZ and any ticker you trade — then tracks every position and per-strategy win rate.
